Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant



Status:Completed
Conditions:Lymphoma, Psychiatric
Therapuetic Areas:Oncology, Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:10/19/2018
Start Date:April 20, 2011
End Date:September 14, 2018

Use our guide to learn which trials are right for you!

A Randomized Multicenter Study Comparing Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma Who Have Relapsed After Therapy With CHOP-R or an Equivalent Regimen and Are Ineligible for Stem Cell Transplant

The purpose of this study is to evaluate the efficacy of Pixantrone + Rituximab compared to
Gemcitabine + Rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma
(DLBCL), or follicular grade 3 lymphoma.

Eligible patients will be randomized to treatment with pixantrone plus rituximab or
gemcitabine plus rituximab in up to six 28-day cycles. At the time patients experience
progressive disease during study treatment, early follow- up, or intermediate follow-up, they
enter the survival follow up period. Patients who complete study treatment or discontinue
study treatment for any other reason will participate in the follow-up periods.

Early Follow-Up: After treatment completion or discontinuation, patient will enter a 24-week
follow-up period.

Intermediate Follow-Up: After completing the 24-week early follow-up period, patient will
enter an additional 72-week follow-up period.

Survival Follow-Up: All patients will be monitored for survival.

Inclusion Criteria:

1. Diagnosis of DLBCL (de novo DLBCL, or transformed from indolent lymphoma) or
follicular grade 3 lymphoma on the basis of tissue biopsy.

2. Patients with de novo DLBCL must have received 1-3 treatment regimens for DLBCL.
Patients with follicular grade 3 lymphoma must have received 1-3 treatment regimens
for follicular lymphoma (any grade). Patients with DLBCL transformed from indolent
lymphoma must have received at least 1-4 treatment regimens for NHL.

3. Received rituximab containing a multi-agent therapy for the treatment of NHL.

4. Not eligible for high-dose chemotherapy and stem cell transplant.

5. Patients with DLBCL transformed from indolent lymphoma must have had a complete or
partial response to a therapy for NHL lasting at least 12 weeks.

Exclusion Criteria:

1. Primary refractory de novo DLBCL or primary refractory follicular grade 3 lymphoma,
defined as documented progression within 12 weeks of the last cycle of the first-line
multi-agent regimen.

2. Prior treatment with cumulative dose of doxorubicin or equivalent exceeding 450 mg/m2

3. Any experimental therapy ≤ 28 days prior to randomization

4. Other malignancy within last 5 years except for the following: curatively treated
basal cell/squamous cell skin cancer, carcinoma in situ of the cervix, superficial
transitional cell bladder carcinoma, or in situ ductal carcinoma of the breast after
complete resection

5. Any contraindication or known allergy or hypersensitivity to any study drugs

6. Concomitant therapy with any anticancer agents, immunosuppressive agents, other
investigational anticancer therapies. Low-dose corticosteroids for the treatment of
non cancer-related illnesses are permitted.
We found this trial at
51
sites
Lincoln, Nebraska 68506
Principal Investigator: Madhu Midathada, MD
Phone: 402-484-4907
?
mi
from
Lincoln, NE
Click here to add this to my saved trials
Aurora, Colorado 80012
Principal Investigator: David Andorsky, MD
Phone: 303-285-5064
?
mi
from
Aurora, CO
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bentonville, Arkansas 72703
Principal Investigator: J. Thaddeus Beck, MD
Phone: 479-872-8130
?
mi
from
Bentonville, AR
Click here to add this to my saved trials
6410 Rockledge Dr #660
Bethesda, Maryland 20817
(301) 571-0019
Principal Investigator: Victor Priego, MD
Phone: 301-571-2016
Center for Cancer & Blood Disorders Widely recognized for its compassionate, expert care, the Center...
?
mi
from
Bethesda, MD
Click here to add this to my saved trials
Boulder, Colorado 80303
Principal Investigator: David Andorsky, MD
Phone: 303-285-5064
?
mi
from
Boulder, CO
Click here to add this to my saved trials
4875 Higbee Ave NW
Canton, Ohio 44718
330-492-3345
Principal Investigator: Nashat Gabrail, MD
Gabrail Cancer Center Since 1990, Gabrail Cancer Center has built a national reputation for excellence...
?
mi
from
Canton, OH
Click here to add this to my saved trials
Columbia, Missouri 65201
?
mi
from
Columbia, MO
Click here to add this to my saved trials
Danville, Illinois 61832
Principal Investigator: James Egner, MD
Phone: 217-383-4085
?
mi
from
Danville, IL
Click here to add this to my saved trials
Decatur, Illinois 62526
Principal Investigator: James Wade, MD
Phone: 217-876-4758
?
mi
from
Decatur, IL
Click here to add this to my saved trials
Denver, Colorado 80218
Principal Investigator: David Andorsky, MD
Phone: 303-285-5064
?
mi
from
Denver, CO
Click here to add this to my saved trials
Dover, Ohio 44622
Principal Investigator: Nashat Gabrail, MD
Phone: 330-492-3345
?
mi
from
Dover, OH
Click here to add this to my saved trials
East Setauket, New York 11733
Principal Investigator: Jeffrey Vacirca, MD
Phone: 631-751-3000
?
mi
from
East Setauket, NY
Click here to add this to my saved trials
Effingham, Illinois 62401
Principal Investigator: James Wade, MD
Phone: 217-876-4758
?
mi
from
Effingham, IL
Click here to add this to my saved trials
Fayetteville, Arkansas 72703
Principal Investigator: J. Thaddeus Beck, MD
Phone: 479-872-8130
?
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Fridley, Minnesota 55432
Principal Investigator: Daniel M Anderson, MD
Phone: 952-993-3252
?
mi
from
Fridley, MN
Click here to add this to my saved trials
Grand Rapids, Michigan 49450
Principal Investigator: Timothy O'Rourke, MD
Phone: 616-954-5550
?
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Green Bay, Wisconsin 54301
Principal Investigator: Anthony Jaslowski, MD
Phone: 920-433-8889
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
Green Bay, Wisconsin 54303
Principal Investigator: Anthony Jaslowski, MD
Phone: 920-433-8889
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
Greenville, South Carolina 29615
Principal Investigator: Fahd Quddus, MD
Phone: 864-255-1517
?
mi
from
Greenville, SC
Click here to add this to my saved trials
Hardeeville, South Carolina 29927
Principal Investigator: Gary Thomas, MD
Phone: 843-689-9267
?
mi
from
Hardeeville, SC
Click here to add this to my saved trials
Hilton Head Island, South Carolina 29926
Principal Investigator: Gary Thomas, MD
Phone: 843-689-9267
?
mi
from
Hilton Head Island, SC
Click here to add this to my saved trials
?
mi
from
Innsbruck,
Click here to add this to my saved trials
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Louisville, Kentucky 40207
Principal Investigator: Leela Bhupalam, MD
Phone: 502-897-1166
?
mi
from
Louisville, KY
Click here to add this to my saved trials
Lubbock, Texas 79410
Principal Investigator: Donald Quick, MD
Phone: 806-725-8065
?
mi
from
Lubbock, TX
Click here to add this to my saved trials
Maplewood, Minnesota 55109
Principal Investigator: Daniel M Anderson, MD
Phone: 952-993-3252
?
mi
from
Maplewood, MN
Click here to add this to my saved trials
Mattoon, Illinois 61938
Principal Investigator: James Egner, MD
Phone: 217-383-4085
?
mi
from
Mattoon, IL
Click here to add this to my saved trials
Morristown, New Jersey 07962
Principal Investigator: Charles Farber, MD
Phone: 973-538-3593
?
mi
from
Morristown, NJ
Click here to add this to my saved trials
New Braunfels, Texas 78130
Principal Investigator: Roger M Lyons, MD
Phone: 210-595-5324
?
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Orange Park, Florida 32073
?
mi
from
Orange Park, FL
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19111
Principal Investigator: Stefan Barta, MD
Phone: 215-728-2207
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Portland, Oregon 97213
Principal Investigator: Kathryn Kolibaba, MD
Phone: 360-597-1061
?
mi
from
Portland, OR
Click here to add this to my saved trials
Portland, Oregon 97213
?
mi
from
Portland, OR
Click here to add this to my saved trials
Roanoke, Virginia 24014
Principal Investigator: Jennifer Vaughn, MD
Phone: 540-982-0237
?
mi
from
Roanoke, VA
Click here to add this to my saved trials
Saint Louis Park, Minnesota 55416
?
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
640 Jackson Street
Saint Paul, Minnesota 55101
?
mi
from
Saint Paul, MN
Click here to add this to my saved trials
San Antonio, Texas 78229
Principal Investigator: Roger M Lyons, MD
Phone: 210-595-5324
?
mi
from
San Antonio, TX
Click here to add this to my saved trials
Toledo, Ohio 43617
Principal Investigator: Rex Mowat, MD
Phone: 419-843-6147
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Toledo, Ohio 43623
Principal Investigator: Rex Mowat, MD
Phone: 419-843-6147
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Toledo, Ohio 43623
Principal Investigator: Rex Mowat, MD
Phone: 419-843-6147
?
mi
from
Toledo, OH
Click here to add this to my saved trials
Tualatin, Oregon 97062
Principal Investigator: Kathryn Kolibaba, MD
Phone: 360-597-1061
?
mi
from
Tualatin, OR
Click here to add this to my saved trials
Tucson, Arizona 85712
Principal Investigator: Manuel Modiano, MD
Phone: 520-290-2510
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
Tucson, Arizona 85745
Principal Investigator: Manuel Modiano, MD
Phone: 520-290-2510
?
mi
from
Tucson, AZ
Click here to add this to my saved trials
602 W University Ave
Urbana, Illinois 61801
(217) 383-3010
Principal Investigator: James Egner, MD
Phone: 217-353-4085
Carle Cancer Center Carle Cancer Center delivers comprehensive care through leading-edge technology and advanced research,...
?
mi
from
Urbana, IL
Click here to add this to my saved trials
Vancouver, Washington 98684
Principal Investigator: Kathryn Kolibaba, MD
Phone: 360-597-1061
?
mi
from
Vancouver, WA
Click here to add this to my saved trials
Vancouver, Washington 98684
?
mi
from
Vancouver, WA
Click here to add this to my saved trials
Washington, District of Columbia 20037
?
mi
from
Washington,
Click here to add this to my saved trials
818 N. Emporia, #403
Wichita, Kansas 67214
(316) 262-4467
Principal Investigator: Shaker Dakhil, MD
Phone: 316-613-4314
Cancer Center of Kansas The physicians of Cancer Center are hematologists and oncologists. The staff...
?
mi
from
Wichita, KS
Click here to add this to my saved trials
818 N. Emporia, #403
Wichita, Kansas 67214
(316) 262-4467
Cancer Center of Kansas The physicians of Cancer Center are hematologists and oncologists. The staff...
?
mi
from
Wichita, KS
Click here to add this to my saved trials